Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Epigenomic regulation of stemness contributes to the low immunogenicity of the most mutated human cancer

Cell Reports(2025)10.1016/j.celrep.2025.115561Source: DataRank Database

Epigenomic regulation of stemness contributes to the low immunogenicity of the most mutated human cancer is a research paper published in Cell Reports (2025). On theSindex it has a DataRank of 0. It has been cited 3 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access3 citations

Download PDF

Cite:

Linked data & code

geo gen

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 1.23)OA: goldTopics (62)IDs (PubMed, PMC, OpenAlex)Annotations (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (12)

Sabrina S. Smith,Valeria S Oliver-Garcia ORCID,Truelian Lee,Heehwa G. Son ORCID,Mahsa Mortaja

Live enrichment

PubMed:40250424 PMC:PMC12149994 OpenAlex:https://openalex.org/W4409540274

National Institute of Arthritis and Musculoskeletal and Skin Diseases

Grant: R01AR076013

Burroughs Wellcome Fund

Society for Pediatric Dermatology

LEO Foundation

National Institutes of Health

FWCI

1.23

Citation Percentile

0.8%

Citation Trend

2025

2026

goldLicense: cc-by-nc-nd

journalhttps://doi.org/10.1016/j.celrep.2025.115561

publisherhttps://doi.org/10.1016/j.celrep.2025.115561

publisherhttps://api.elsevier.com/content/article/PII:S2211124725003328?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2211124725003328?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/40250424

Fields of Study

Epigenetics and DNA MethylationHedgehog Signaling Pathway StudiesCancer Cells and MetastasisHumansAnimalsMiceSkin NeoplasmsBasal Cell CarcinomaMutationPyridinesBenzamidesEpigenomicsForkhead Transcription FactorsImmunotherapyImiquimodHistocompatibility Antigens Class INeoplastic Stem CellsCarcinoma, Squamous CellCell Line, TumorEpigenesis, GeneticGene Expression Regulation, Neoplastic

MeSH Terms

ImiquimodAnimalsBenzamidesCarcinoma, Basal CellBasal Cell CarcinomaCarcinoma, Squamous CellHumansImmunotherapyMutationPyridinesSkin NeoplasmsNeoplastic Stem CellsHistocompatibility Antigens Class IGene Expression Regulation, NeoplasticEpigenesis, GeneticCell Line, TumorMiceForkhead Transcription FactorsEpigenomics

Keywords

EpigenomicsImmunogenicityCancerCancer researchBiologyComputational biologyGeneticsCell biologyGeneDNA methylationGene expressionImmune systemImmunotherapyHLA-IBasal Cell CarcinomaHair Follicle Stem CellCutaneous Squamous Cell CarcinomaIrf1EntinostatFoxc1Cp: CancerAntigen Processing And Presentation Machinery

Epigenomic regulation of stemness contributes to the low immunogenicity of the most mutated human cancer

FAIR Checklist

Authors (12)

Funding (5 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)